Archives of Pathology & Laboratory Medicine · 2014 · 44 citations · 24 references
MedicineHematologyImmunologyAutoimmunityClinical ImmunologyTransfusion MedicineAnemiaClinical HematologyHematologic DisordersRed Blood Cell DisordersRed Blood Cell TransfusionRh AlloimmunizationAlloantibody DetectionPhenotype MatchingRh C Antigen AlloimmunizationRh D AlloimmunizationRh E Antigen AlloimmunizationThalassemia Transfusion
CONTEXT: Thalassemia is a major health problem in Egypt. Red blood cell alloimmunization is an important complication in transfusion-dependent patients. OBJECTIVES: To determine alloimmunization prevalence in Egyptian patients with β-thalassemia and to evaluate risk factors that could influence alloimmunization, with the hope of minimizing transfusion-associated risks in those patients. DESIGN: Records of 272 patients with β-thalassemia who are receiving regular blood transfusions, matched for ABO-Rh(D), were analyzed. Alloantibody identification was performed by DiaMed-ID microtyping system. Autoantibodies were detected by direct Coombs test. RESULTS: Alloimmunization incidence was 22.8% with 123 alloantibodies detected in 62 patients. The most common alloantibody was Rh-related (37.4%; 46 of 123), comprising anti-E (14.6%; 18 of 123), anti-D (8.9%; 11 of 123), anti-C (8.9%; 11 of 123), and anti-c (4.9%; 6 of 123), followed by anti-Kell (26%; 32 of 123), → anti-MNS (9.8%; 12 of 123), → anti-Kidd (8.9%; 11 of 123) → anti-Duffy (8.1%; 10 of 123), → anti-Le (5.7%; 7 of 123), → anti-Lu (2.4%; 3 of 123), and → anti-P1 (1.6%; 2 of 123). Anti-D antibodies developed in 34.5% of all Rh-negative patients. Eighty percent of all anti-D antibodies developed in patients older than 18 years. Males had the highest alloimmunization incidence. Alloimmunization incidence increased with the number of units transfused (P = .01). Patients who received unfiltered blood had a higher alloimmunization rate than did those who always received leukoreduced blood (P < .001). Splenectomized patients had a higher alloimmunization rate (32%; 40 of 125) than did those who did not have a splenectomy (16.3%; 24 of 147; P = .003). Autoantibodies occurred in 1.5% (4 of 272) of all patients. CONCLUSION: Transfusion of leukoreduced and phenotypically matched cells for selective antigens may help reduce expenses and risks of alloimmunization in patients with thalassemia.
24
Standards for blood banks and transfusion services.
PubMed · 1977 · 1.2K citations
WF Rosse, Dympna Gallagher, TR Kinney et al. · Blood · 1990 · 491 citations · Full text
Medicine, Hematology, Immunology +12
RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients
Reem Ameen, Salem Alshemmari, Salah Al‐Humood et al. · Transfusion · 2003 · 169 citations
Medicine, Hematology, Immunology +11
Incidence of red cell antibodies after multiple blood transfusion
Cornelia Fluit, V.A.J.M. Kunst, Alice Drenthe-Schonk · Transfusion · 1990 · 132 citations
Medicine, Hematology, Immunology +17